<DOC>
	<DOC>NCT00397891</DOC>
	<brief_summary>Evaluate safety, tolerability, and pharmacokinetics of single doses of the investigational AAB-001 Vaccine in Japanese patients with Alzheimer's disease.</brief_summary>
	<brief_title>Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis of AD Age 5085 MMSE 1426 Other Inclusion Criteria Apply Significant Neurological Disease Major Psychiatric Disorder Clinically Significant Systemic Illness Other Exclusion Criteria Apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>